Speaker Profile
Edmund Pezalla

Edmund Pezalla MD, MPH, PhD

Pharmacy and Medicine, Health Care Policy and Research
Wethersfield, Connecticut, United States of America

Connect with the speaker?

Edmund Pezalla, M.D., MPH, is Aetna's leading executive for issues related to pharmaceutical development, reimbursement strategy, and drug evaluation. He is active on projects in both the public and private sectors including: CDC and FDA as well as MIT's Center for Biomedical Innovation. Recently Dr. Pezalla served as a consultant for the President's Council of Advisors on Science and Technology for their report: Propelling Innovation in Drug Discovery, Development and Evaluation. Dr. Pezalla is also a member of the Advisory Board of the Connecticut Innovations Biosciences Fund.

Dr. Pezalla is currently leading Aetna's innovative partnership initiatives with device and pharmaceutical manufacturers including pay-for-performance and shared risk programs.

Previously Dr. Pezalla was Chief Clinical Officer for Aetna Pharmacy Management from July 2007 to July 2010. In that role he was responsible for formulary development, quality and utilization programs and clinical strategy. Prior to joining Aetna Dr. Pezalla was VP of clinical services at Prescription Solutions, the wholly owned PBM subsidiary of United Health.

Dr. Pezalla is a graduate of Georgetown University College of Arts and Sciences and Georgetown University School of Medicine. He also holds an MPH from the School of Public Health, University of California at Berkeley and completed a research fellowship and post-doctoral studies at the University of Michigan Schools of Medicine and Public Health.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)